1. Home
  2. PHVS vs IE Comparison

PHVS vs IE Comparison

Compare PHVS & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • IE
  • Stock Information
  • Founded
  • PHVS 2015
  • IE 2020
  • Country
  • PHVS Switzerland
  • IE United States
  • Employees
  • PHVS N/A
  • IE N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • IE Metal Mining
  • Sector
  • PHVS Health Care
  • IE Basic Materials
  • Exchange
  • PHVS Nasdaq
  • IE Nasdaq
  • Market Cap
  • PHVS 980.9M
  • IE 1.0B
  • IPO Year
  • PHVS 2021
  • IE 2022
  • Fundamental
  • Price
  • PHVS $22.32
  • IE $10.28
  • Analyst Decision
  • PHVS Buy
  • IE Strong Buy
  • Analyst Count
  • PHVS 6
  • IE 3
  • Target Price
  • PHVS $37.17
  • IE $12.67
  • AVG Volume (30 Days)
  • PHVS 33.8K
  • IE 1.1M
  • Earning Date
  • PHVS 08-13-2025
  • IE 08-06-2025
  • Dividend Yield
  • PHVS N/A
  • IE N/A
  • EPS Growth
  • PHVS N/A
  • IE N/A
  • EPS
  • PHVS N/A
  • IE N/A
  • Revenue
  • PHVS N/A
  • IE $3,276,000.00
  • Revenue This Year
  • PHVS N/A
  • IE $64.50
  • Revenue Next Year
  • PHVS N/A
  • IE $0.73
  • P/E Ratio
  • PHVS N/A
  • IE N/A
  • Revenue Growth
  • PHVS N/A
  • IE N/A
  • 52 Week Low
  • PHVS $11.51
  • IE $4.50
  • 52 Week High
  • PHVS $25.76
  • IE $12.13
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 73.31
  • IE 70.20
  • Support Level
  • PHVS $17.63
  • IE $8.91
  • Resistance Level
  • PHVS $19.00
  • IE $10.52
  • Average True Range (ATR)
  • PHVS 1.20
  • IE 0.57
  • MACD
  • PHVS 0.35
  • IE 0.07
  • Stochastic Oscillator
  • PHVS 92.15
  • IE 91.06

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

Share on Social Networks: